[1]
Łęczycka, A. et al. 2026. PHARMACOTHERAPY IN MUSCLE DYSMORPHIC DISORDER: CLINICAL CONSIDERATIONS AND THE LIMITS OF EXTRAPOLATING EVIDENCE FROM BODY DYSMORPHIC DISORDER. International Journal of Innovative Technologies in Social Science. 3, 2(50) (Jun. 2026). DOI:https://doi.org/10.31435/ijitss.2(50).2026.5359.